Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Watch Bernstein's Liang on China's Edge in Pharma Sector
Bernstein's Liang on China's Edge in Pharma Sector China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing. Rebecca Liang, a senior analyst…
Indian Stock Markets Rebound: Sun Pharma Acquisition, Global Cues Drive Gains
Indian benchmark indices Sensex and Nifty staged a significant rebound in early trade, buoyed by Sun Pharma's major acquisition of US-based Organon & Co and positive global market trends, ending a three-day period of decline. Benchmark indices…
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Sun Pharmaceutical Industries Ltd is set to acquire US-based Organon & Co for a staggering $11.75 billion, a strategic move poised to significantly expand its global footprint and elevate its standing among the world's top pharmaceutical companies.
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women's health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years. Sun Pharma will pay $14 per Organon share in cash, giving the…
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share. The acquisition will…
Sun Pharma To Purchase US-listed Organon In A Nearly $11.8 billion Deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals. The acquisition would help Sun Pharma further expand its women's…
Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries Ltd has announced that it has entered into a definitive agreement under which it will acquire all outstanding shares of Organon for $14.00 per share in an all‑cash transaction with an enterprise valuation of…
Focus on these 4 pharma stocks: Sun Pharma, Zydus, Alembi, Rubicon on Monday
Sun Pharmaceutical Industries and US-based Organon & Co have entered into an agreement under which Sun will acquire all outstanding shares of Organon for $14 per share in an all-cash transaction with an enterprise valuation of $11.75 billion…
Sun Pharma to acquire Organon for $11.75 bn: How this will expand US footprint, why the timing is significant
5 min read Mumbai Make us preferred source on Google In a significant overseas acquisition, Sun Pharmaceutical Industries, India's largest pharmaceutical company, and US-based Organon & Co have announced that they have entered into a definitive…
Sun Pharma shares surge over 5% on $11.75-billion Organon deal
Shares of Sun Pharmaceutical Industries jumped more than 5 per cent in early trade on Monday after the company announced a landmark acquisition of US-based Organon & Co in a deal valued at $11.75 billion, marking the largest overseas buy by the…
HC Wainwright Predicts Urogen Pharma Q1 Earnings
3 Bullish Biotech Stocks With Explosive Growth Trends Urogen Pharma (NASDAQ:URGN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of Urogen Pharma in a report issued on Thursday…
Sun Pharma surges 7%, Sensex tops 77,200 at noon; Shriram Finance, Axis Bank drag
Markets held firm through Monday's mid-session trade, with the BSE Sensex at 77,244.65, up 580.44 points or 0.76 per cent, and the Nifty 50 at 24,076.65, up 178.70 points or 0.75 per cent, as of 12.45 pm — building on a positive opening that…
Markets shrug off geopolitical gloom, open higher on GIFT Nifty signals; Sun Pharma leads, Axis Bank bleeds
Equity benchmarks opened in positive territory on Monday morning, defying a string of headwinds including elevated crude oil prices and continued foreign institutional selling, as GIFT Nifty signalled a gap-up start for domestic indices. The BSE…
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Ma
Organon & Co. (NYSE:) said on Sunday it signed a definitive agreement to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion. According to the terms of the agreement, Organon shareholders will receive $14 per…
Stock markets bounce back after three days of decline
Benchmark indices Sensex and Nifty rebounded in early trade on Monday after three days of decline, tracking a rally in Sun Pharma and a positive trend in global equity markets. The 30-share BSE Sensex jumped 546.64 points to 77,210.85 in early…
Receive a Daily briefing on Pharma Industry News
Get Started